Jean-yves Y. Cahn
Grenoble, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 179 publications
Intermediate-Dose Cytarabine as Postinduction AML Therapy.
Journal: NEJM evidence
Published: June 24, 2025
Rapid response system for critically ill patients with haematological malignancies: A pre- and post-intervention study.
Journal: European journal of haematology
Published: January 24, 2024
Correction to: An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis.
Journal: Bone marrow transplantation
Published: March 17, 2022
Association of Chronic Graft-versus-Host Disease with Late Effects following Allogeneic Hematopoietic Cell Transplantation for Children with Hematologic Malignancy.
Journal: Transplantation and cellular therapy
Published: February 01, 2022
Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis.
Journal: Transplantation and cellular therapy
Published: January 06, 2022
Correction to: Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation.
Journal: Bone marrow transplantation
Published: May 21, 2021
An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis.
Journal: Bone marrow transplantation
Published: May 13, 2021
Conventional chemotherapy for acute myeloid leukemia in older adults: Impact on nutritional, cognitive, and functional status.
Journal: European journal of haematology
Published: December 07, 2020
Last Updated: 09/26/2026